analyst
RC
NASDAQ · RCEL
AVITA Medical, Inc.
Healthcare · Medical - Devices
$9.86
Down-$0.30 (-2.95%)
Updated Sep 11, 2026, 4:45 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 94.53M
- P/E ratio
- -1.8
- Dividend yield
- 0.00%
- 52-week range
- $3.22 – $11.39
- Volume
- 245.4K
- Avg. volume
- 574.48K
Price performance
RCEL price history
1M range · 20 trading sessions · Daily adjusted prices
RCEL closed at $9.86 after 20 trading sessions, up 23.10% for the selected period.
- Last close
- $9.86
- Period change
- +23.10%
- Period low
- $7.85
- Period high
- $11.20
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $10.00 | $10.34 | $9.80 | $9.86 | 245.4K |
| Sep 9, 2026 | $10.32 | $10.495 | $10.11 | $10.16 | 154.5K |
| Sep 8, 2026 | $11.23 | $11.23 | $10.33 | $10.41 | 312.05K |
| Sep 4, 2026 | $10.99 | $11.39 | $10.80 | $11.20 | 301.85K |
| Sep 3, 2026 | $10.90 | $11.20 | $10.70 | $10.94 | 320.14K |
| Sep 2, 2026 | $10.10 | $10.87 | $10.065 | $10.76 | 542.59K |
| Sep 1, 2026 | $10.02 | $10.29 | $9.97 | $10.07 | 142.65K |
| Aug 31, 2026 | $10.26 | $10.29 | $9.84 | $10.10 | 182.77K |
| Aug 28, 2026 | $10.48 | $10.65 | $10.15 | $10.35 | 203.88K |
| Aug 27, 2026 | $10.41 | $10.5282 | $10.1411 | $10.32 | 254.25K |
| Aug 26, 2026 | $10.53 | $10.71 | $10.14 | $10.59 | 287.84K |
| Aug 25, 2026 | $10.04 | $10.77 | $9.93 | $10.50 | 452.19K |
| Aug 24, 2026 | $10.09 | $10.22 | $9.66 | $9.91 | 222.28K |
| Aug 21, 2026 | $10.30 | $10.39 | $9.9158 | $10.06 | 301.36K |
| Aug 20, 2026 | $10.15 | $10.34 | $9.89 | $10.09 | 413.51K |
| Aug 19, 2026 | $9.83 | $10.415 | $9.25 | $10.34 | 789.2K |
| Aug 18, 2026 | $7.94 | $10.20 | $7.72 | $9.85 | 1.43M |
| Aug 17, 2026 | $7.91 | $8.15 | $7.74 | $7.90 | 194.16K |
| Aug 14, 2026 | $8.01 | $8.17 | $7.66 | $7.85 | 270.99K |
| Aug 13, 2026 | $8.08 | $8.55 | $7.94 | $8.01 | 404.03K |
Latest RCEL news
The latest Smart Investors Daily articles mentioning RCEL.
Stock researchResearch & News · SEC Filings
Loading stock research…